IGF-1 LR3
ResearchIGF-1 LR3 (Long Arg3-IGF-1)
- Category
- Growth Hormone
- Aliases
- Long R3 IGF-1, Long-Arg3-IGF-1
- Administration
- Subcutaneous injection
Research and regulatory
Development stage
Preclinical/laboratory research compound; no known human clinical trials.
Legal and regulatory
Unscheduled research compound; not FDA approved. Prohibited by WADA for competitive athletes.
Side effects
Hypoglycemia risk (insulin-like activity), potential for uncontrolled tissue growth with misuse, injection site reactions